期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
载脂蛋白B/A-1比值与2型糖尿病慢性并发症的相关研究进展
1
作者 田佳敏 李社莉 《临床医学进展》 2024年第8期807-811,共5页
糖尿病的发生率逐渐升高,尤其是2型糖尿病。随着糖尿病病程的增加,各项并发症的发病率也随之升高。尤其是2型糖尿病导致的慢性并发症,对人们的健康、心理及经济等各个方面均有一定的影响。近几年的研究均表明了脂质代谢对糖尿病的发病... 糖尿病的发生率逐渐升高,尤其是2型糖尿病。随着糖尿病病程的增加,各项并发症的发病率也随之升高。尤其是2型糖尿病导致的慢性并发症,对人们的健康、心理及经济等各个方面均有一定的影响。近几年的研究均表明了脂质代谢对糖尿病的发病机制及其并发症的发生及进展有一定的影响。载脂蛋白B/A-1比值作为新的代谢紊乱标志物的指标之一,可评价糖尿病患者血管相关并发症。本文就载脂蛋白B/A-1比值在2型糖尿病血管并发症中的作用的相关研究进行综述。The prevalence of type 2 diabetes is on the rise, leading to an increase in associated complications over time. In particular, the chronic complications caused by type 2 diabetes have a certain impact on people’s health, psychology and economy. Recent studies have highlighted the impact of lipid metabolism on the development and progression of diabetes-related complications. Given that the ApoB/A-1 ratio can serve as a valuable indicator for assessing metabolic disorders and evaluating chronic complications in patients with diabetes. This review provides an overview of relevant research concerning the role of ApoB/A-1 ratio in vascular complications of type 2 diabetes. 展开更多
关键词 蛋白B/a-1比值 2型糖尿病 糖尿病慢性并发症
下载PDF
老年冠心病患者血清脂蛋白A-1、胱抑素C、同型半胱氨酸水平与冠状动脉粥样硬化的相关性分析 被引量:10
2
作者 蔡云峰 《中国卫生检验杂志》 CAS 2023年第4期479-481,486,共4页
目的 分析老年冠心病(CHD)患者血清脂蛋白A-1(apoA-1)、胱抑素C(Cys C)、同型半胱氨酸(Hcy)水平与冠状动脉粥样硬化的相关性。方法 选取本院2019年11月-2021年9月收治的110例CHD患者为观察组,另选取同期同院110例体检健康者为对照组。根... 目的 分析老年冠心病(CHD)患者血清脂蛋白A-1(apoA-1)、胱抑素C(Cys C)、同型半胱氨酸(Hcy)水平与冠状动脉粥样硬化的相关性。方法 选取本院2019年11月-2021年9月收治的110例CHD患者为观察组,另选取同期同院110例体检健康者为对照组。根据Gensini积分将观察组患者分为轻度硬化组(n=30)、中度硬化组(n=35)及重度硬化组(n=45)。比较2组患者血清apoA-1、Cys C、Hcy水平;比较不同冠状动脉粥样硬化患者血清apoA-1、Cys C、Hcy水平;分析Gensini积分与血清apoA-1、Cys C、Hcy水平的相关性。结果 与对照组相比,观察组患者血清apoA-1水平均明显降低,而Cys C、Hcy水平明显升高(P<0.05)。与轻度硬化组相比,中度硬化组及重度硬化组患者血清apoA-1水平均较低,而Cys C、Hcy水平较高;与中度硬化组相比,重度硬化组患者血清apoA-1水平均较低,而Cys C、Hcy水平较高(P<0.05)。与轻度硬化组相比,中度硬化组及重度硬化组患者Gensini积分较高;与中度硬化组相比,重度硬化组患者Gensini积分较高(P<0.05)。Gensini积分与血清apoA-1水平均成负相关(r=-0.883,P<0.001),与Cys C、Hcy水平成正相关(r=0.846、r=0.848,P<0.001)。apoA-1、Cys C、Hcy为老年冠心病独立预测因素(P<0.05)。结论 血清apoA-1、Cys C、Hcy水平与老年CHD患者冠脉病变程度均存在不同程度相关性,低水平apoA-1及高水平的Cys C、Hcy均可增加老年人发生CHD风险,临床通过检测血清apoA-1、Cys C、Hcy水平可有效预测老年CHD的发生。 展开更多
关键词 老年冠心病 脂蛋白a-1 胱抑素C 同型半胱氨酸 冠状动脉粥样硬化 相关性
原文传递
Low plasma apolipoprotein A-1 level is not a reliable marker of fibrosis in children with chronic hepatitis B 被引量:1
3
作者 Mukadder Ayse Selimoglu Rasit Vural Yagcl Gül Yüce 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第19期2864-2866,共3页
AIM: To evaluate the clinical value of plasma apolipoprotein A-I (Apo A-I) as a marker of fibrosis in children with chronic hepatitis B (CHB).METHODS: Liver biopsy specimens from 49 children with CHB were evaluated by... AIM: To evaluate the clinical value of plasma apolipoprotein A-I (Apo A-I) as a marker of fibrosis in children with chronic hepatitis B (CHB).METHODS: Liver biopsy specimens from 49 children with CHB were evaluated by using Knodell index. Plasma Apo A-I level was measured after 12-h fasting. Student's ttest, Spearman's correlation test and receptor-operating characteristic (ROC) curve were used for statistical evaluation.RESULTS: Mean Apo A-I level of the patients was not different from that of controls (P>0.05). Six (8.7%) children had fibrosis score of more than 2 (severe fibrosis). No difference in the level of mean plasma Apo A-I was found among children with and without severe fibrosis (P>0.05). No correlation between Apo A-I level and fibrosis scores was found (P>0.05). The area under the ROC curve was 0.407~0.146 (P>0.05).CONCLUSION: Severe fibrosis is not common in children with CHB and plasma Apo A-I level is not a reliable indicator of fibrosis. 展开更多
关键词 阿朴脂蛋白a-1 低血浆 纤维化 慢性乙型肝炎 HBV 受体
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部